Onkologie. 2016:10(4):196-198 | DOI: 10.36290/xon.2016.043

Extraventricular, supratentorial ependymomas. Two case reports

Ondřej Kalita1, Miroslav Vaverka1, Miloslava Zlevorová2, Yvona Klementová2, Magdalena Megová3
1 Neurochirurgická klinika LF UP a FN Olomouc
2 Onkologická klinika LF UP a FN Olomouc
3 Ústav molekulární a translační medicíny LF UP v Olomouci

Extraventicular, supratentorial ependymomas are very rare tumors in adults. Thus, factors affecting prognosis are poorly understood.

These case reports present two male patient who was evaluated for first epileptic seazures, respectively for increasing headaches,

nausea and vomiting. Both MRI scans showed extraventricular tumors in right brain temporal lobe. Radical tumor extirpations

were performed. Histology revealed anaplastic ependmoma WHO gr. III. Subsequently, both patients received radiotherapy. The

first patient had tumor recurrencies with repeated surgery and chemotherapies. He expirated 29 months after diagnosis. The

second patient has been showed no tumor recurrency to this date, 77 months after diagnosis. Several studies confirmed tumor

location as an important prognostic factor in adult intracranial ependymomas. However it is seems genetic features to be a more

important biomarker. So far standard treatment of these ependymomas stay radical surgery followed by radiotherapy. The lack of

unequivocal rules for chemotherapy in ependymoma recurrency provides an opportunity for using even less common regimens.

Keywords: anaplastic ependymoma, prognosis, survival, biomarkers

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalita O, Vaverka M, Zlevorová M, Klementová Y, Megová M. Extraventricular, supratentorial ependymomas. Two case reports. Onkologie. 2016;10(4):196-198. doi: 10.36290/xon.2016.043.
Download citation




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.